Persistent Spike Protein Syndrome

Persistent Spike Protein Syndrome

Résolution rapide par irradiation ultraviolette du sang

Rapport de Fabrice Leu, ND et Thomas E. Levy, MD, JD

OMNS (September 27, 2023) This article will outline what appears to be a highly successful, readily accessible, and inexpensive therapy for dealing with the Persistent Spike Protein Syndrome, commonly referred to as chronic COVID or « long-haul » COVID, as applied and reported by Dr. Fabrice Leu of Switzerland. Long-term follow-up on the treated patients remains to be accumulated to determine whether the positive clinical and laboratory outcomes are temporary or permanent. Regardless, the therapy can be applied in minutes in the office setting, and even if there is a periodic resurgence/recurrence of spike protein in any of the patients it can be repeatedly addressed as needed. This therapy can offer a great deal of relief to millions of people continuing to suffer with the symptoms of persistent spike protein after their acute COVID infections and/or following one or more vaccinations. Whether the spike protein can ever be completely eradicated (versus just chronically suppressed) remains an issue of great concern to clinicians and their patients.

Research is now showing that the spike protein can become effectively « embedded » into the genome. [1,2] Ils rapportent une détection de la protéine Spike dans le sang de certaines personnes vaccinées jusqu’à six mois. [3]

La disparition de la protéine de la circulation ne signifierait pas nécessairement, selon l’article, sa disparition complète de l’organisme.

Bref historique de l’irradiation UV

Niels Finsen, médecin danois, reçut le prix Nobel de physiologie ou médecine en 1903 pour ses travaux pionniers de photothérapie des maladies cutanées. Après avoir étudié les effets du soleil sur des insectes et des animaux, il s’intéressa aux ultraviolets. Un collègue souffrait de lupus vulgaire, dû à la même bactérie que la tuberculose pulmonaire, résistant aux traitements de l’époque. Finsen observa une amélioration rapide après irradiation UV des zones atteintes. L’arrivée des antibiotiques relégua cette approche au second plan, mais ses travaux contribuèrent aux recherches sur la stérilisation par UV. La capacité des UV à inactiver ou détruire des agents pathogènes, notamment pour désinfecter l’air, est aujourd’hui bien établie. [4-7] L’agent responsable de la COVID peut également être inactivé par irradiation UV. [8]

L’article affirme que l’irradiation UV du sang peut résoudre rapidement diverses maladies infectieuses. Il cite une série de 47 patients atteints de poliomyélite spinale précoce à modérée, tous décrits comme guéris par cette seule intervention.

D’autres infections et affections, notamment des hépatites virales aiguës et des septicémies avancées, sont décrites comme guéries ou nettement améliorées. [9,10]

D-dimères et persistance de la protéine Spike

Les auteurs relient la persistance de la protéine Spike après COVID ou vaccination à une élévation des D-dimères sanguins. Les D-dimères proviennent de la dégradation des caillots. Une élévation peut donc indiquer une activité accrue de formation et de dégradation des caillots. [11] Selon les auteurs, un taux normal n’exclut pas complètement la présence de Spike, mais une nouvelle élévation en serait un indicateur chez un patient infecté ou vacciné. Ils citent des autopsies rapportant des microthrombi dans l’organisme de 80 à 100% des patients atteints de COVID. [12] L’article rapporte que les D-dimères sont presque toujours élevés chez les patients COVID et que les valeurs les plus hautes annoncent des résultats moins favorables. [13,14] Une étude prospective citée a observé une élévation chez 137 patients COVID consécutifs, corrélée à la gravité clinique de l’infection. [15] Après la phase aiguë, une persistance de la protéine Spike pendant plusieurs mois a été rapportée. [16]

La protéine Spike est décrite comme favorisant directement la formation de caillots dans l’organisme. [17,18] Les auteurs considèrent qu’on ne peut conclure à son contrôle ou à son élimination tant que les D-dimères restent élevés.

La persistance de D-dimères élevés indique une activité anormale de formation et de dissolution des caillots et est associée à une mortalité accrue. Les auteurs évoquent aussi bien des maladies favorisant la thrombose que la persistance de Spike après infection ou vaccination. [19-21] L’article propose d’utiliser les D-dimères, plus accessibles que le dosage de Spike, pour suivre indirectement la présence et la quantité de protéine dans le sang. Pour les auteurs, leur normalisation serait un argument en faveur de l’élimination ou de la forte réduction de Spike circulante. Une analyse de cette pathologie et de traitements bio-oxydatifs a déjà été publiée. [22]

Continuing research on COVID, vaccination status, and the Persistent Spike Protein Syndrome is now demonstrating that many, possibly a majority, of the sickest chronic COVID patients also received vaccinations. This should not be surprising, since the culprit agent in those ill individuals is the spike protein, and the purported mechanism of the shot is to disseminate mRNA-generated spike protein throughout the body in order to stimulate an immune response to the pathogen containing the spike protein.

Regardless of any generated immune response, the spike protein has its own well-documented toxicity, and continued spike protein production long after such an initial response to an mRNA vaccine is resulting in a wide range of chronic diseases and medical conditions. Spike protein toxicity is well-documented now in both human and animal studies.

Même des fragments de protéine Spike sont décrits dans l’article comme toxiques et fortement pathogènes. [23-25]

Les auteurs rappellent que la toxicité et le pouvoir pathogène de protéines Spike liées au coronavirus SARS-CoV ont été étudiés avant la pandémie de COVID. [26,27] Ils citent une étude animale où un vaccin exprimant une protéine Spike liée au SARS-CoV n’a pas protégé contre l’agent ciblé et a provoqué une forte inflammation avec nécrose hépatique. Les animaux exposés mais non vaccinés ne présentaient pas de symptômes cliniques. Les auteurs s’interrogent sur le rôle physiologique du vaccin dans cette expérience. [28]

L’article affirme que les injections avant ou après une COVID augmentent la quantité de Spike, parfois durablement, et que certaines cellules ayant assimilé l’ARNm pourraient continuer à en produire pendant une durée indéterminée. [29,30] Une étude citée rapporte que 12% des 720 personnes ayant reçu un vaccin induisant la production de Spike ont rapidement présenté une élévation des D-dimères. [31] Inducing an abnormal clotting status in any patient at any time is never desirable and should not be part of any « normal » vaccination response.

UV Blood Irradiation and COVID-Related Elevated D-Dimer levels

Patients with the symptoms of chronic COVID and having elevated D-Dimer levels were treated with a protocol of UV blood irradiation. These chronic COVID patients, clinically felt to have the persistent presence of the spike protein in their blood and elsewhere, had any of the multiple symptoms commonly reported now, including cognitive and mental impairment, pain in the chest, joints, and muscles, loss or alteration of smell and taste, cough, headache, and various gastrointestinal problems. [32]

Un appareil Kastner d’irradiation UV du sang a été utilisé. [33] L’appareil émet des UV-C à 254 nm, longueur d’onde décrite comme particulièrement absorbée par les protéines étrangères et provoquant leur dénaturation. [34,35] Les UV-C perturbent aussi l’ARN et l’ADN et peuvent ainsi inactiver les agents pathogènes. L’article indique que bactéries et virus absorbent environ cinq fois plus d’énergie photonique que les globules rouges et blancs circulants.

Les auteurs citent des travaux sur la déstructuration de Spike par les UV-C et la réduction de sa liaison au récepteur ACE2, mécanisme qu’ils relient à la coagulation et aux lésions tissulaires et organiques. [36,37]

Patients with a D-Dimer level in excess of 500 ng/cc (or 0.5 mg/L) were included in the treatment group. The goal, in addition to symptom relief, was to bring the D-Dimer levels to less than 500, the level considered to be normal. However, it should be noted that having a D-Dimer level between 200 and 300 is more desirable than « just below » 500. A laboratory reference range, or « normal » range is based on statistical considerations that assume normalcy in most of the tested patients. Such a range fails miserably when a substantial percentage of the tested population is not normal.

Irradiation UV-C en un passage : Le protocole décrit utilisait 50 cc de sang veineux et 5 cc de citrate de sodium dans une seringue de 60 cc, avec un passage dans l’appareil UV-C. Le sang était ensuite réinjecté par voie veineuse à environ 1 cc toutes les trois secondes. Le tube en cristal transparent habituel avait été remplacé par une tubulure ASID de 75 cm, moins coûteuse. Démonstration vidéo de la technique : https://rumble.com/v3i5kd8-ultraviolet-blood-irradiation-1-pass.html.

Irradiation UV-C en passages multiples avec ajout d’oxygène : Some of the patients also received hematogenic oxygen therapy (HOT) before the UV-C irradiation treatment of the blood. This utilizes one 60 cc syringe filled with oxygen gas connected to one end of the ASID line inside the UV-C device. The other end is connected to another 60 cc syringe with 50 cc of venous blood and 5 cc of sodium citrate. Once both ends of the ASID line are connected to their respective syringes, the contents of the oxygen syringe and the blood syringe are pushed back-and-forth in a « ping-pong » fashion through the irradiated ASID line for roughly 150 seconds. Significant foaming will be noted. The remaining non-foamed blood is then administered back to the patient intravenously. For a video demonstration of this technique: https://rumble.com/v3i59hm-hematogenic-oxydation-therapy.html. Another video more clearly demonstrates the « ping-pong » aspect of this technique: https://rumble.com/v3j379q-dubai-practitionner.html

Résultats cliniques et biologiques

Cette observation ne constituait pas une étude de grande ampleur, strictement contrôlée. Les auteurs jugent néanmoins les résultats marquants. Dix patients ont reçu soit un passage d’UV-C seul, soit plusieurs passages dans la tubulure irradiée avec ajout de 60 cc d’oxygène dans le circuit fermé avant restitution du sang.

Deux patients ont reçu uniquement un passage d’UV-C. One was 74-years-old who received 4 UV-C one pass treatments over a 4-month period. The D-Dimer improved but did not normalize, going from 863 to 741.

The other patient was a 20-year-old male serving in the Swiss military. He had never been vaccinated. The military required COVID testing routinely every few weeks. He had developed significant pressure in his head for one to two weeks before being seen. As was required on a regular basis in the military, he had a COVID test which came back positive. He received a one pass UV-C treatment, and this was repeated 2 weeks later. His head discomfort resolved, and his D-Dimer went from slightly elevated at 519 to normal at 382. This patient alone not only demonstrates the effectiveness of UV-C blood irradiation, it also strongly implies that the circulating spike protein might be completely eliminated quite easily when such a therapy is given early-on.

Huit patients ont reçu plusieurs passages d’UV-C associés à la HOT : 3 patients, ages ranging from 65 to 89 were treated. One (65-years-old) had an initial D-Dimer of 2,976. After two treatments separated by a 6-week period the D-Dimer level had dropped to 591. A 58-year-old who presented with a D-Dimer of 1,121 was given two treatments over a 1-week period. The D-Dimer level plummeted to 310. The 89-year-old had a very impressive result, with an initial D-Dimer of 1,996 dropping to 357 with 2 treatments given over a 6-week period.

5 more patients, ages ranging from 40 to 73, presented with symptoms of chronic COVID. 4 of 5 were treated with a single UV-C multi-pass + HOT therapy. No follow-up treatments were given, as these individuals felt well and did not feel the need to return for more treatment or follow-up testing. As a result no follow-up D-Dimer test could be done. The 40-year-old ended up receiving 2 treatments, and did not return after that. Initial D-Dimer levels ranged from 571 to 1,002. While yet to be precisely defined, such positive clinical responses appear to closely correlate with a declining/normalizing D-Dimer level.

Exceptional Safety

Ultraviolet blood irradiation has an impressive track record of safety over the many years of its application as a therapy. However, it is essential that the therapy be applied as recommended and not be « overdosed » as can occur with virtually any therapeutic agent or medicine. UV irradiation at the wavelength described in this article has been shown to be preferentially absorbed into the nucleic acid of the pathogens that are present while leaving the blood proteins unharmed. Because of this safety profile and pathogen-killing effectiveness, such UV irradiation is commonly used for reducing the infectivity of pathogens in plasma and other blood components harvested for subsequent administration in both animals and humans. [38,39]

L’irradiation UV du sang total associée à la riboflavine a été décrite comme réduisant fortement l’infectiosité de Plasmodium falciparum (agent du paludisme), sans hémolyse importante. [40] Une autre étude citée rapporte une réduction importante des agents pathogènes sans dommage significatif aux globules rouges. [41] Bien que les UV augmentent le stress oxydatif dans les pathogènes, l’article rapporte une augmentation de la capacité antioxydante de l’albumine, principale protéine sanguine. [42]

Les auteurs distinguent l’irradiation du sang de l’exposition directe de la peau aux UV. Comme lors d’un coup de soleil, différentes longueurs d’onde peuvent endommager la peau en cas d’exposition excessive. [43] Ils insistent sur l’importance de la quantité totale et de la vitesse d’application. Une même énergie peut avoir des effets très différents selon son administration. Ils rappellent que certaines applications contrôlées d’UV sont utilisées pour des affections dermatologiques. [44]

Selon le témoignage cité, aucun effet indésirable négatif significatif n’a été observé parmi plus de 1'000 patients traités à la Riordan Clinic de Wichita, Kansas. [45]

Le protocole de cette clinique prélève 60 à 300 cc de sang, le dilue dans un volume plusieurs fois supérieur de sérum physiologique et l’ozone hors du corps. La solution est réinjectée en 30 à 90 minutes par une tubulure passant dans un appareil UV. Une perfusion de vitamine C, généralement de 50 g, suit le traitement. L’article mentionne aussi des publications russes décrivant de rares effets indésirables légers et transitoires. [46] Also, there is a substantial variation among irradiation device wavelengths and the treatment protocols being utilized around the world. Nevertheless, it appears that regardless of wavelength and protocol, UV blood irradiation is an exceptionally safe and effective procedure.

Beyond its ability to kill pathogens and neutralize toxins, UV blood irradiation has been documented to result in many different positive biochemical, clinical, and metabolic changes in the treated patients. These changes have been examined in depth in review articles. [9,47]

Conclusions

The application of UV irradiation has been known to be a powerful anti-pathogen therapy for well over a century. It has been proven to be highly effective for external disinfection as well as for internal infection remediation. It remains incredibly underutilized around the world, likely due to lack of awareness along with the continuous pressure to use only costly pharmacological agents for just about everything.

Les auteurs préconisent, en raison de ce qu’ils décrivent comme une diffusion mondiale de Spike, un dosage initial des D-dimères chez tout patient présentant un symptôme ou une affection.

Ils considèrent qu’une persistance de Spike pourrait imiter ou aggraver de nombreuses affections et qu’un résultat positif nécessiterait une intervention urgente, as delay will give any circulating spike protein an increased chance of becoming embedded inside the cells and tissues, with a persistent presence that can last for the life of the patient. Spike protein is most susceptible to destruction and elimination while in the blood.

A série de traitements UV pourrait, selon l’article, améliorer les résultats chez les patients présentant des D-dimères élevés attribués à Spike circulante.

Les auteurs espèrent que cette observation pilote suscitera de nouvelles recherches cliniques sur l’irradiation UV du sang comme thérapie bio-oxydative pour les infections, dont la COVID, et d’autres affections.

Ils renvoient à plusieurs revues sur des affections non infectieuses traitées par cette méthode dans la littérature antérieure aux antibiotiques. [9,10,48]

Recap

The COVID-related spike protein is currently a major cause for much of the morbidity and mortality around the world today. It can be present when an acute COVID infection does not completely resolve but instead evolves into chronicity. Vaccines, as they are designed to introduce more spike protein into the body, make it even harder to obliterate or even minimize the long-term spike protein content in the blood. It is also increasingly clear that many people can acquire a significant spike protein exposure through shedding, or casual contact with someone else harboring the spike protein. This literally puts everyone at some risk, and D-Dimer simply must become a test as routine as glucose, cholesterol, or hemoglobin.

While a wide array of therapies and supplements have been proposed to deal with the Persistent Spike Protein Syndrome, many do not result in a high degree of clinical resolution. Bio-oxidative therapies, including vitamin C, hydrogen peroxide, ultraviolet light, ozone, and hyperbaric oxygen are all very valuable in treating such patients.

This paper reports on a limited experience with UV blood irradiation therapies for the treatment of symptomatic patients with elevated D-Dimer levels. In the context of the pandemic, it appears that the unique thrombogenic nature of the spike protein reliably results in elevations of these levels. No matter how minimal a symptom might seem, an elevated D-Dimer mandates immediate and vigorous therapy. With its documented ability to dénaturer et éliminer la protéine Spike, de son coût et de sa facilité d’administration, ils proposent d’inclure l’irradiation UV précocement lorsqu’elle est disponible.

(Fabrice Leu est naturopathe avec diplôme fédéral et formateur avec brevet fédéral. Il est président de l’ASNFD, Association suisse des naturopathes avec diplôme fédéral. Voir www.asnfd.org. Il exerce la médecine naturopathique depuis 30 ans et utilise fréquemment des thérapies bio-oxydatives, notamment l’irradiation UV du sang, l’autohémothérapie à l’ozone et la vitamine C intraveineuse. Contact : ecolecmn@gmail.com.

(Thomas E. Levy, MD, JD est spécialiste certifié en médecine interne et maladies cardiovasculaires, ainsi qu’avocat. Contact : televymd@yahoo.com. A collection of all his OMNS articles can be accessed with the following link under the subheading of « Orthomolecular »: https://www.peakenergy.com/health_ebytes.php )

 

Références

1. Alden M, Falla F, Yang D et al. (2022) Intracellular reverse transcription of Pfizer BioNTech COVID-19 mRNA vaccine BNT162b2 in vitro in human liver cell line. Current Issues in Molecular Biology 44:1115-1126. PMID: 35723296

2. Zhang L, Bisht P, Flamier A et al. (2023) LINE1-mediated reverse transcription and genomic integration of SARS-CoV-2 mRNA detected in virus-infected but not in viral mRNA-transfected cells. Viruses 15:629. PMID: 36992338

3. Brogna C, Cristoni S, Marino G et al. (2023) Detection of recombinant spike protein in the blood of individuals vaccinated against SARS-CoV-2: possible molecular mechanisms. Proteomics. Clinical Applications Aug 31; e2300048. Online ahead of print. PMID: 37650258

4. Reed N (2010) The history of ultraviolet germicidal irradiation for air disinfection. Public Health Reports 125:15-27. PMID: 20402193

5. Welch D, Buonanno M, Grilj V et al. (2018) Far-UVC light: a new tool to control the spread of airborne-mediated microbial diseases. Scientific Reports, 8:2752. PMID: 29426899

6. Yang J, Wu U, Tai H, Sheng W (2019) Effectiveness of an ultraviolet-C disinfection system for reduction of healthcare-associated pathogens. Journal of Microbiology, Immunology, and Infection 52:487-493. PMID: 28951015

7. Ma B, Bright K, Ikner L et al. (2023) UV inactivation of common pathogens and surrogates under 222 nm irradiation fro KrCl* excimer lamps. Photochemistry and Photobiology 99:975-982. PMID: 36129750

8. Heilingloh C, Aufderhorst U, Schipper L et al. (2020) Susceptibility of SARS-CoV-2 to UV irradiation. American Journal of Infection Control. 48:1273-1275. PMID: 32763344

9. Rowen R (1996) Ultraviolet blood irradiation therapy (photo-oxidation), the cure that time forgot. International Journal of Biosocial and Medical Research 14:115-132l https://www.drmichaelschoenwalder.com/wp-content/uploads/2020/12/Ultraviolet-Blood-Irradiation-Therapy-Photo-Oxidation-The-Cure-That-Time-Forgot.pdf

10. Hamblin M (2017) Ultraviolet blood irradiation of blood: « The cure that time forgot? » Advances in Experimental Medicine and Biology 996:295-309. PMID: 29124710

11. Weitz J, Fredenburgh J, Eikelboom J (2017) A test in context: D-Dimer. Journal of the American College of Cardiology, 70:2411-2420. PMID: 29096812

12. Kong J, Yang T, Zhang F et al. (2023) Pulmonary fat embolism: a potentially new fatal complication of SARS-CoV-2 infection. A case report. BMC Infectious Diseases 23:576. PMID: 37667198

13. Rostami M, Mansouritorghabeh H (2020) D-dimer level in COVID-19 infection: a systematic review. Expert Review of Hematology, 13:1265-1275. PMID: 32997543

14. Asakura H, Ogawa H (2021) COVID-19-associated coagulopathy and disseminated intravascular coagulation. International Journal of Hematology, 113:45-57. PMID: 33161508

15. Trofin F, Nastase E, Rosu M et al. (2023) Inflammatory response in COVID-19 depending on the severity of the disease and the vaccination status. International Journal of Molecular Sciences, 24:8550. PMID: 37239895

16. Townsend L, Fogarty H, Dyer A et al. (2021) Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. Journal of Thrombosis and Haemostasis, 19:1064-1070. PMID: 33587810

17. Ryu J, Sozmen E, Dixit K et al. (2021) SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy. bioRxiv Oct13, Preprint. PMID: 34671772

18. Robles J, Zamora M, Adan-Castro E et al. (2022) The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling. The Journal of Biological Chemistry 298:101695. PMID: 35143839

19. Halaby R, Popma C, Cohen A et al. (2015) D-Dimer elevation and adverse outcomes. Journal of Thrombosis and Thrombolysis 39:55-59. PMID: 25006010

20. Kolotylo T, Moskaliuk V, Syrota B et al. (2023) Evaluation of D-Dimer level as a biomarker of disease severity and mortality in patients with COVID-19. Wiadomosci Lekarskie, 76:1636-1641. PMID: 37622508

21. Punzalan F, Aherrera J, de Paz-Silava S et al. (2023) Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital. Frontiers in Immunology 14:1123497. PMID: 36926338

22. Levy T (2023) http://orthomolecular.org/resources/omns/v19n15.shtml

23. Fernandes B, Feitosa N, Barbosa A et al. (2022) Toxicity of spike fragments SARS-CoV-2 S protein for zebrafish: a tool to study its hazardous for human health. The Science of the Total Environment 813:152345. PMID: 24942250

24. Seneff S, Kyriakopoulos A, Nigh G, McCullough P (2023) A potential role of the spike protein in neurodegenerative diseases: a narrative review. Cureus 15:e34872. PMID: 36788995

25. Cao S, Song Z, Rong J et al. (2023) Spike protein fragments promote Alzheimer’s amyloidogenesis. ACS Applied Materials & Interfaces 15:40317-40329. PMID: 37585091

26. Kuba K, Imai Y, Rao S et al. (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nature Medicine 11:875-879. PMID: 16007097

27. Lesgards J, Cerdan D, Perronne C et al. (2023) Toxicity of SARS-CoV-2 spike protein from the virus and produced from COVID-19 mRNA or adenoviral DNA vaccines. Archives of Microbiology & Immunology 7:121-138.

28. Czub M, Weingartl H, Czub S et al. (2005) Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets. Vaccine 23:2273-2279. PMID: 15755610

29. Cosentino M, Marino F (2022) The spike hypothesis in vaccine-induced adverse effects: questions and answers. Trends in Molecular Medicine 28:797-799. PMID: 36114089

30. Parry P, Lefringhausen A, Turni C et al. (2023) « Spikeopathy »: COVID-19 spike protein is pathogenic, from both virus and vaccine mRNA. Biomedicines 11:2287. PMID: 37626783

31. Boonyawat K, Phojanasenee T, Noikongdee P et al. (2023) Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais. Thrombosis Journal 21:92. PMID: 37674185

32. Young S (2021) Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infectious Diseases 53:737-754. PMID: 34024217

33. https://www.ozontherapie.com/products/ultraviolet/

34. Santos A, Moreirinha C, Lopes D et al. (2013) Effects of UV radiation on the lipids and proteins of bacteria studied by mid-infrared spectroscopy. Environmental Science & Technology 47:6306-6315. PMID: 23692317

35. Ruzza P, Honisch C, Hussain R, Siligardi G (2021) Free radicals and ROS induce protein denaturation by UV photostability assay. International Journal of Molecular Sciences 22:6512. PMID: 34204483

36. Mahanta N, Sharma S, Sharma L et al. (2022) Unfolding of the SARS-CoV-2 spike protein through infrared and ultraviolet-C radiation based disinfection. International Journal of Biological Macromolecules 221:71-82. PMID: 36063893

37. Strizzi S, Bernardo L, D’Ursi P et al. (2023) An innovative strategy to investigate microbial protein modifications in a reliable fast and sensitive way: a therapy oriented proof of concept based on UV-C irradiation of SARS-CoV-2 spike protein. Pharmacological Research 194:106862. PMID: 37479104

38. Seltsam A, Muller T (2011) UVC irradiation for pathogen reduction of platelet concentrates and plasma. Transfusion Medicine and Hemotherapy 38:43-54. PMID: 21779205

39. Blazquez E, Rodriguez C, Rodenas J et al. (2019) UV-C irradiation is able to inactivate pathogens found in commercially collected porcine plasma as demonstrated by swine bioassay. Veterinary Microbiology 239:108450. PMID: 31753544

40. Chaar M, Atwal S, Freimanis G et al. (2019) Inactivation of Plasmodium falciparum in whole blood by riboflavin plus irradiation. Transfusion 53:3174-3183. PMID: 23656538

41. Zhang Q, Wu C, Fan Y et al. (2020) Nucleic acid-targeted pathogen reduction technique in red blood cells by UV-generated oxygen radicals for optimizing recipient safety. Transfusion Medicine 30:51-60. PMID: 31823441

42. Yang J, Fan G, Tan F et al. (2023) The role of UVA and UVB in UV-induced skin erythema. Frontiers in Medicine 10:1163697. PMID: 37441686

43. Christensen L, Suggs A, Baron E (2017) Ultraviolet photobiology in dermatology. Advances in Experimental Medicine and Biology 996:89-104. PMID: 29124693

44. Sozarukova M, Skachko N, Chilikina P et al. (2023) Effect of low-dose line-spectrum and full-spectrum UV on major humoral components of the human blood. Molecules 28:4646. PMID: 37375200

45. Communication de Ron Hunninghake, MD, directeur médical, Riordan Clinic, Wichita, Kansas

46. Marochkov A, Doronin V, Kravtsov N (1990) [Complications in ultraviolet irradiation of the blood]. Article in Russian. Anesteziologiia i Reanimatologiia 4:55-56. PMID: 2077972

47. Wu X, Hu X, Hamblin M (2016) Ultraviolet blood irradiation: is it time to remember « the cure that time forgot »? Journal of Photochemistry and Photobiology. B, Biology 157:89-96. PMID: 26894849

48. Boretti A, Banik B, Castelletto S (2021) Use of ultraviolet blood irradiation against viral infections. Clinical Reviews in Allergy & Immunology 60:259-270. PMID: 33026601

Nutritional Medicine is Orthomolecular Medicine

Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org